Li Guangming, Zhao Juanjuan, Cheng Liang, Jiang Qi, Kan Sheng, Qin Enqiang, Tu Bo, Zhang Xin, Zhang Liguo, Su Lishan, Zhang Zheng
The Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States of America.
Research Center for Clinical & Translational Medicine, Beijing 302 Hospital, Beijing, China.
PLoS Pathog. 2017 Jul 31;13(7):e1006505. doi: 10.1371/journal.ppat.1006505. eCollection 2017 Jul.
Chronic human immunodeficiency virus-1 (HIV-1) infection in patients leads to multi-lineage hematopoietic abnormalities or pancytopenia. The deficiency in hematopoietic progenitor cells (HPCs) induced by HIV-1 infection has been proposed, but the relevant mechanisms are poorly understood. We report here that both human CD34+CD38- early and CD34+CD38+ intermediate HPCs were maintained in the bone marrow (BM) of humanized mice. Chronic HIV-1 infection preferentially depleted CD34+CD38- early HPCs in the BM and reduced their proliferation potential in vivo in both HIV-1-infected patients and humanized mice, while CD34+CD38+ intermediate HSCs were relatively unaffected. Strikingly, depletion of plasmacytoid dendritic cells (pDCs) prevented human CD34+CD38- early HPCs from HIV-1 infection-induced depletion and functional impairment and restored the gene expression profile of purified CD34+ HPCs in humanized mice. These findings suggest that pDCs contribute to the early hematopoietic suppression induced by chronic HIV-1 infection and provide a novel therapeutic target for the hematopoiesis suppression in HIV-1 patients.
人类免疫缺陷病毒1型(HIV-1)慢性感染患者会导致多谱系造血异常或全血细胞减少。尽管已有研究提出HIV-1感染会导致造血祖细胞(HPC)缺乏,但相关机制仍不清楚。我们在此报告,人源化小鼠骨髓中可维持人CD34+CD38-早期造血祖细胞和CD34+CD38+中间造血祖细胞。慢性HIV-1感染优先消耗人源化小鼠骨髓中的CD34+CD38-早期造血祖细胞,并降低其在体内的增殖潜能,而CD34+CD38+中间造血干细胞相对未受影响。引人注目的是,浆细胞样树突状细胞(pDC)的消耗可防止人CD34+CD38-早期造血祖细胞因HIV-1感染而耗竭和功能受损,并恢复人源化小鼠中纯化的CD34+造血祖细胞的基因表达谱。这些发现表明,pDC促成了慢性HIV-1感染诱导的早期造血抑制,并为HIV-1患者造血抑制提供了新的治疗靶点。